-+ 0.00%
-+ 0.00%
-+ 0.00%

CULLINAN THERAPEUTICS INC - PHASE 1 CLN-049 MONOTHERAPY DEMONSTRATES PROMISING EFFICACY

路透·12/08/2025 15:34:10

登錄查看新聞詳情